119 related articles for article (PubMed ID: 2473898)
1. Synergistic induction of cytogenetic damage by alkylating antineoplastics and 5-azacytidine in human lymphocytes.
Ioannidou E; Lialiaris T; Mourelatos D; Dozi-Vassiliades J
Environ Mol Mutagen; 1989; 14(1):6-12. PubMed ID: 2473898
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of cytogenetic damage by chlorpromazine in human lymphocytes treated with alkylating antineoplastics and caffeine.
Lialiaris T; Mourelatos D; Dozi-Vassiliades J
Mutat Res; 1988 Nov; 206(3):361-5. PubMed ID: 3200257
[TBL] [Abstract][Full Text] [Related]
3. Effects of alkylating antineoplastics alone or in combination with 3-aminobenzamide on genotoxicity, antitumor activity, and NAD levels in human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo.
Petrou C; Mourelatos D; Mioglou E; Dozi-Vassiliades J; Catsoulacos P
Teratog Carcinog Mutagen; 1990; 10(4):321-31. PubMed ID: 1980034
[TBL] [Abstract][Full Text] [Related]
4. Induction of sister-chromatid exchanges and cell-cycle delays in human lymphocytes by vitamin A alone or in combination with melphalan and caffeine.
Dozi-Vassiliades J; Myrtsiotis A; Granitsas A; Mourelatos D
Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1089-92. PubMed ID: 4065180
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of cytogenetic damage by inhibitors of poly(ADP-ribose)polymerase in human lymphocytes exposed to antineoplastics in vivo and in vitro.
Mourelatos D; Kourakis A; Koliouskas DE; Hatzitheodoridou P; Dozi-Vassiliades J
Teratog Carcinog Mutagen; 1986; 6(6):485-92. PubMed ID: 2881364
[TBL] [Abstract][Full Text] [Related]
6. Synergistic induction of sister-chromatid exchanges in lymphocytes from normal subjects and from patients under cytostatic therapy by inhibitors of poly(ADP-ribose)polymerase and antitumour agents.
Mourelatos D; Kourakis A; Dozi-Vassiliades J; Tsiouris J; Hatzitheodoridou P
Mutat Res; 1985 Aug; 143(4):225-30. PubMed ID: 2991758
[TBL] [Abstract][Full Text] [Related]
7. Effect of 5-azacytidine (5-azaC) on the induction of chromatid aberrations (CA) and sister-chromatid exchanges (SCE).
Lavia P; Ferraro M; Micheli A; Olivieri G
Mutat Res; 1985 May; 149(3):463-7. PubMed ID: 2581131
[TBL] [Abstract][Full Text] [Related]
8. Comparison of current alkylating agents with a homo-aza-steroidal ester for antineoplastic activity.
Catsoulacos P; Papageorgiou A; Margarity E; Mourelatos D; Mioglou E
Oncology; 1994; 51(1):74-8. PubMed ID: 8265107
[TBL] [Abstract][Full Text] [Related]
9. Different efficiencies of interaction between 3-aminobenzamide and various monofunctional alkylating agents in the induction of sister chromatid exchanges.
Schwartz JL; Morgan WF; Weichselbaum RR
Carcinogenesis; 1985 May; 6(5):699-704. PubMed ID: 4006055
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandins act synergistically with antitumour agents on induction of sister chromatid exchanges in human lymphocytes.
Dozi-Vassiliades J; Mourelatos D
Prostaglandins Leukot Med; 1985 Jan; 17(1):55-9. PubMed ID: 3919400
[TBL] [Abstract][Full Text] [Related]
11. Sister chromatid exchanges in lymphocytes of nurses handling antineoplastic drugs.
Sardaş S; Gök S; Karakaya AE
Toxicol Lett; 1991 Mar; 55(3):311-5. PubMed ID: 2003274
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumour alkylating agents act synergistically with methylxanthines on induction of sister-chromatid exchange in human lymphocytes.
Mourelatos D; Dozi-Vassiliades J; Granitsas A
Mutat Res; 1982; 104(4-5):243-7. PubMed ID: 7202117
[No Abstract] [Full Text] [Related]
13. Dependency of the yield of sister-chromatid exchanges induced by alkylating agents on fixation time. Possible involvement of secondary lesions in sister-chromatid exchange induction.
Kaina B; Aurich O
Mutat Res; 1985 May; 149(3):451-61. PubMed ID: 3990696
[TBL] [Abstract][Full Text] [Related]
14. Sister-chromatid exchanges and cell-cycle kinetics in human lymphocyte cultures exposed to alkylating mutagens: apparent deformity in dose-response relationships.
Morimoto K; Sato-Mizuno M; Koizumi A
Mutat Res; 1985; 152(2-3):187-96. PubMed ID: 3934535
[TBL] [Abstract][Full Text] [Related]
15. Persistence of cytogenetic damage induced by alkylating antineoplastic drug phopurinum in human lymphocytes in vivo and in vitro.
Lazutka JR; Slapsyte G
Cancer Lett; 1990 Nov; 54(3):113-8. PubMed ID: 2224839
[TBL] [Abstract][Full Text] [Related]
16. Induction of sister chromatid exchanges and cell division delays in human lymphocytes by the anti-tumour agent homo-aza-steroidal ester of p-bis(2-chloroethyl)aminophenoxy acetic acid.
Tselepi MR; Demopoulos NA; Catsoulacos P
Mutagenesis; 1989 Sep; 4(5):361-4. PubMed ID: 2687630
[TBL] [Abstract][Full Text] [Related]
17. Enhanced cytogenetic and antitumor effects by 9-nitrocamptothecin and antineoplastics.
Karaberis E; Mourelatos D
Teratog Carcinog Mutagen; 2000; 20(3):141-6. PubMed ID: 10820424
[TBL] [Abstract][Full Text] [Related]
18. Adaptation-like response to the chemical induction of sister chromatid exchanges in human lymphocytes.
Morimoto K; Sato-Mizuno M; Koizumi A
Hum Genet; 1986 May; 73(1):81-5. PubMed ID: 3086210
[TBL] [Abstract][Full Text] [Related]
19. Synergistic induction of cytogenetic damage by the homo-aza-steroidal ester of p-bis(2-chloroethyl)aminophenylacetic acid in combination with caffeine in human lymphocytes in vitro and in Ehrlich ascites tumour cells in vivo.
Petrou C; Mourelatos D; Dozi-Vassiliades J; Catsoulacos P
Mutat Res; 1990 Feb; 243(2):109-13. PubMed ID: 2304481
[TBL] [Abstract][Full Text] [Related]
20. N-Methyl-N-nitrosourea potentiation of cytogenetic damage induced by 1,3-bis(2-chloroethyl)-1-nitrosourea in normal human lymphocytes.
Wiencke JK; Bodell WJ
Cancer Res; 1985 Oct; 45(10):4798-803. PubMed ID: 4027969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
